APP and Alzheimer disease: β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) serves as a central molecule, cleaving amyloid precursor protein (APP) to generate toxic amyloid-β (Aβ) peptides, leading to Aβ peptide aggregation and plaque formation in the brain, thereby initiating the progression of AD [2,3].